Document Detail


Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody.
MedLine Citation:
PMID:  8072835     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Respiratory syncytial virus (RSV) is responsible for serious respiratory disease in young infants. More than 75% of the 678 children hospitalized for RSV at Baylor-affiliated hospitals in Houston, TX, between October, 1992, and March, 1993, were 5 months of age or younger. The importance of maternal antibody in the immunity against RSV disease has been debated. More recent epidemiologic studies have demonstrated protection against RSV in babies born to mothers with high levels of neutralizing RSV antibody. The contribution of IgG fusion or F protein antibody as a correlate with immunity from disease also has been described. With the availability of purified F protein vaccines such as the purified F protein vaccines manufactured by Lederle-Praxis-Biologicals (Pearl River, NY), immunization of pregnant women with RSV surface glycoproteins to arm the newborn with high neutralizing antibody can be considered. Advantages of maternal immunization to augment naturally occurring maternal RSV antibody are that babies most at risk for infection are least responsive to vaccines, that pregnant women respond well immunologically to vaccines in general and that placental transfer of maternal IgG antibody occurs naturally during the third trimester. The safety of maternally derived antibody would likely surpass that of exogenously administered immunoglobulin as well as would have a decreased cost. Disadvantages of maternal immunization to protect infants against RSV could include the potential inhibition of the infant's response to active immunization or subsequent disease, the lack of antibody transfer in premature infants, and liability issues. Evaluation of purified F protein vaccine in postpartum women is under way.
Authors:
J A Englund
Related Documents :
22885205 - Genetic analysis of ha gene of pandemic h1n1 2009 influenza viruses circulating in india.
1246465 - Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or...
25363635 - Human papillomavirus genotype-specific prevalence across the continuum of cervical neop...
9470415 - Dermatophytes isolated from asymptomatic stray cats.
17627505 - Hiv-1-discordant couples in sub-saharan africa: explanations and implications for high ...
2968945 - Prevalence of isolated antibody to hepatitis b core antigen in an area endemic for hepa...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  The Pediatric infectious disease journal     Volume:  13     ISSN:  0891-3668     ISO Abbreviation:  Pediatr. Infect. Dis. J.     Publication Date:  1994 May 
Date Detail:
Created Date:  1994-09-29     Completed Date:  1994-09-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8701858     Medline TA:  Pediatr Infect Dis J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  449-53     Citation Subset:  IM    
Affiliation:
Department of Microbiology and Immunology, Baylor College of Medicine, Houston, TX 77030.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Viral / immunology
Female
Humans
Immunity, Maternally-Acquired*
Immunization
Infant
Pregnancy
Pregnancy Complications, Infectious / immunology*
Respiratory Syncytial Virus Infections / etiology,  prevention & control*
Respiratory Syncytial Virus, Human / immunology*
Viral Vaccines / immunology*
Chemical
Reg. No./Substance:
0/Antibodies, Viral; 0/Viral Vaccines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neonatal herpes simplex virus infections: is there a role for immunoglobulin in disease prevention a...
Next Document:  Role of antibody and the use of respiratory syncytial virus immunoglobulin in the prevention of resp...